558 related articles for article (PubMed ID: 15641089)
21. Effect of age on prevalence of anticitrullinated protein/peptide antibodies in polyarticular juvenile idiopathic arthritis.
Dewint P; Hoffman IE; Rogge S; Joos R; Union A; Dehoorne J; Delanghe J; Veys EM; De Keyser F; Elewaut D
Rheumatology (Oxford); 2006 Feb; 45(2):204-8. PubMed ID: 16188943
[TBL] [Abstract][Full Text] [Related]
22. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and concentration of IgM rheumatoid factor in polyarticular onset disease as compared to systemic or pauciarticular onset disease in active juvenile rheumatoid arthritis as measured by ELISA.
Walker SM; Shaham B; McCrudy DK; Wietting H; Arora YK; Hanson V; Bernstein B
J Rheumatol; 1990 Jul; 17(7):936-40. PubMed ID: 2213760
[TBL] [Abstract][Full Text] [Related]
24. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
25. The immunogenetics of juvenile rheumatoid arthritis.
Nepom B
Rheum Dis Clin North Am; 1991 Nov; 17(4):825-42. PubMed ID: 1767076
[TBL] [Abstract][Full Text] [Related]
26. Early predictors of longterm outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations.
Oen K; Malleson PN; Cabral DA; Rosenberg AM; Petty RE; Reed M; Schroeder ML; Cheang M
J Rheumatol; 2003 Mar; 30(3):585-93. PubMed ID: 12610821
[TBL] [Abstract][Full Text] [Related]
27. Association of anti-cyclic citrullinated peptide antibody levels with PADI4 haplotypes in early rheumatoid arthritis and with shared epitope alleles in very late rheumatoid arthritis.
Cha S; Choi CB; Han TU; Kang CP; Kang C; Bae SC
Arthritis Rheum; 2007 May; 56(5):1454-63. PubMed ID: 17469103
[TBL] [Abstract][Full Text] [Related]
28. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
30. The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis.
Korendowych E; Owen P; Ravindran J; Carmichael C; McHugh N
Rheumatology (Oxford); 2005 Aug; 44(8):1056-60. PubMed ID: 15901902
[TBL] [Abstract][Full Text] [Related]
31. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
32. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: relation with clinical features, cytokines and HLA-DRB1].
Correa PA; Tobón GJ; Citera G; Cadena J; Schneeberger E; Camargo JF; Maldonado-Cocco JA; Anaya JM
Biomedica; 2004 Jun; 24(2):140-52. PubMed ID: 15495594
[TBL] [Abstract][Full Text] [Related]
33. DNA analysis of HLA-DR, DQ, and DP alleles in children with polyarticular juvenile rheumatoid arthritis.
Barron KS; Silverman ED; Gonzales JC; Owerbach D; Reveille JD
J Rheumatol; 1992 Oct; 19(10):1611-6. PubMed ID: 1361203
[TBL] [Abstract][Full Text] [Related]
34. Anti-Sa antibodies and antibodies against cyclic citrullinated peptide are not equivalent as predictors of severe outcomes in patients with recent-onset polyarthritis.
Boire G; Cossette P; de Brum-Fernandes AJ; Liang P; Niyonsenga T; Zhou ZJ; Carrier N; Daniel C; Ménard HA
Arthritis Res Ther; 2005; 7(3):R592-603. PubMed ID: 15899046
[TBL] [Abstract][Full Text] [Related]
35. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide.
van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE
Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477
[TBL] [Abstract][Full Text] [Related]
36. Anti-cyclic citrullinated peptide antibodies and IL-23p19 in psoriatic arthritis.
Shibata S; Tada Y; Komine M; Hattori N; Osame S; Kanda N; Watanabe S; Saeki H; Tamaki K
J Dermatol Sci; 2009 Jan; 53(1):34-9. PubMed ID: 18752933
[TBL] [Abstract][Full Text] [Related]
37. Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.
Huizinga TW; Amos CI; van der Helm-van Mil AH; Chen W; van Gaalen FA; Jawaheer D; Schreuder GM; Wener M; Breedveld FC; Ahmad N; Lum RF; de Vries RR; Gregersen PK; Toes RE; Criswell LA
Arthritis Rheum; 2005 Nov; 52(11):3433-8. PubMed ID: 16255021
[TBL] [Abstract][Full Text] [Related]
38. Associations between genetic factors, tobacco smoking and autoantibodies in familial and sporadic rheumatoid arthritis.
Michou L; Teixeira VH; Pierlot C; Lasbleiz S; Bardin T; Dieudé P; Prum B; Cornélis F; Petit-Teixeira E
Ann Rheum Dis; 2008 Apr; 67(4):466-70. PubMed ID: 17660221
[TBL] [Abstract][Full Text] [Related]
39. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
Greiner A; Plischke H; Kellner H; Gruber R
Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
[TBL] [Abstract][Full Text] [Related]
40. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark.
Pedersen M; Jacobsen S; Garred P; Madsen HO; Klarlund M; Svejgaard A; Pedersen BV; Wohlfahrt J; Frisch M
Arthritis Rheum; 2007 May; 56(5):1446-53. PubMed ID: 17469102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
